Rpm.Ad
RPM.AD operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, and generates revenue primarily through its operations in this sector.
Business. RPM.AD operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, and generates revenue primarily through its operations in this sector.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressDavid B. McKinley — RPM International Inc.2021-09-16 · WV · Sale · $15,001 - $50,000
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
RPM.AD operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment, and generates revenue primarily through its operations in this sector.
RPM.AD maintains a relatively strong liquidity position, with a current ratio of 2.75, indicating the company can cover its short-term liabilities with its short-term assets. However, the company has a negative net cash position after subtracting total debt, which introduces some liquidity risk. The debt-to-equity ratio of 0.19 suggests a conservative capital structure, with a low reliance on debt financing.
In terms of profitability, RPM.AD reports a return on equity (ROE) of 20.33% and a return on assets (ROA) of 12.9%, both of which are strong indicators of efficient use of equity and assets. These figures suggest the company is generating solid returns relative to its capital base. The operating margin, calculated as operating income divided by revenue, is 11.04%, which is a key metric for assessing operational efficiency in the healthcare services and equipment industry.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to higher concentration risk, particularly in the event of a downturn in its primary market.
Looking at growth, RPM.AD has demonstrated a strong revenue base of AED 516.05 million, with a gross profit margin of 90.5%, indicating a high level of cost control. However, the company's free cash flow is negative at AED -2.62 million, which may limit its ability to reinvest in growth opportunities without external financing. The capital expenditure of AED -33.32 million suggests the company is investing in its operations, which could support future growth.
The risk assessment for RPM.AD indicates a medium level of liquidity risk, primarily due to the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company has not made any recent public filings or transcripts that would indicate significant changes in its business strategy or financial position.
Recent events and filings do not show any material changes in the company's operations or financial health. The company's financials remain stable, with no indication of significant regulatory or operational disruptions. The absence of recent public disclosures suggests a consistent and stable business environment for RPM.AD.
- RPM.AD has a strong return on equity and return on assets, indicating efficient use of capital.
- The company maintains a conservative debt-to-equity ratio, suggesting a low financial leverage risk.
- The negative free cash flow and negative net cash position after debt may limit the company's ability to fund growth without external financing.
- The lack of geographic and segment diversification increases concentration risk.
- The company's liquidity position is medium risk, primarily due to the negative net cash position after subtracting total debt.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- VP, General Counsel and CCO · Stock Appreciation Rights → Common StockAcquired 17 600 @ $103,04grant · 2026-07-15
- President & COO · Stock Appreciation Rights → Common StockAcquired 48 300 @ $103,04grant · 2026-07-15
- Director, Chairman and CEO · Stock Appreciation Rights → Common StockAcquired 129 500 @ $103,04grant · 2026-07-15
- VP and CFO · Stock Appreciation Rights → Common StockAcquired 26 400 @ $103,04grant · 2026-07-15
- VP, Controller & CAO · Stock Appreciation Rights → Common StockAcquired 4 700 @ $103,04grant · 2026-07-15
- VP Corp. Benefits/Risk Mgmt. · Stock Appreciation Rights → Common StockAcquired 21 500 @ $103,04grant · 2026-07-15
- VP and CFO · Stock Appreciation Rights` → Common StockDisposed 30 000 @ $50,99exercise · 2026-04-28
- VP Corp. Benefits/Risk Mgmt. · Stock Appreciation Rights → Common StockDisposed 30 000 @ $50,99exercise · 2026-04-17
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- RPM.AD Market data — financials · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,25 %$387M
- Investment Managers · as of 2026-03-310,04 %$0M
- Investment Managers · as of 2026-03-310,04 %$52M
- Investment Managers · as of 2026-03-310,04 %$68M
- Investment Managers · as of 2026-03-310,03 %$107M
- Investment Managers · as of 2024-06-300,03 %$1 426M
- Investment Managers · as of 2026-03-310,03 %$450M
- Investment Managers · as of 2026-03-310,03 %$129M
- Investment Managers · as of 2026-03-310,02 %$652M
- Investment Managers · as of 2026-03-310,02 %$48M
- Institutional Investor · as of 2026-03-310,02 %$110M
- Investment Managers · as of 2025-12-310,02 %$1 399M
- Investment Managers · as of 2026-03-310,02 %$124M
- Investment Managers · as of 2026-03-310,02 %$259M
- Institutional Investor · as of 2026-03-310,01 %$41M
- Brokerage Firms · as of 2026-03-310,01 %$45M
- Investment Managers · as of 2026-03-310,01 %$89M
- Institutional Investor · as of 2026-03-310,01 %$54M
- Brokerage Firms · as of 2026-03-310,01 %$48M
- Investment Managers · as of 2026-03-310,01 %$54M
- Investment Managers · as of 2024-12-310,01 %$29M
- Investment Managers · as of 2026-03-310,01 %$54M
- Investment Managers · as of 2026-03-310,01 %$10M
- Funds · as of 2026-03-310,00 %$30M
- Investment Managers · as of 2026-03-310,00 %$14M
- Investment Managers · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$12M
- Institutional Investor · as of 2022-09-300,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$28M
- Institutional Investor · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
- VP-Global Tax and Treasurer · Common Stock, $0.01 par valueOther 670 @ $105,08$70K · 2026-07-19
- VP, Controller & CAO · Common Stock, $0.01 par valueOther 524 @ $105,08$55K · 2026-07-19
- VP Corp. Benefits/Risk Mgmt. · Common Stock, $0.01 par valueOther 1 137 @ $105,08$119K · 2026-07-19
- VP and CFO · Common Stock, $0.01 par valueOther 1 137 @ $105,08$119K · 2026-07-19
- President & COO · Common Stock, $0.01 par valueOther 1 455 @ $105,08$153K · 2026-07-19
- VP, General Counsel and CCO · Common Stock, $0.01 par valueOther 488 @ $105,08$51K · 2026-07-19
- Director, Chairman and CEO · Common Stock, $0.01 par valueOther 3 813 @ $105,08$401K · 2026-07-19
- VP - Operations · Common Stock, $0.01 par valueOther 511 @ $105,08$54K · 2026-07-19
- VP-Global Tax and Treasurer · Common Stock, $0.01 par valueOther 1 500 · 2026-07-15
- VP, Controller & CAO · Common Stock, $0.01 par valueOther 1 005 · 2026-07-15
- VP, Controller & CAO · Common Stock, $0.01 par valueOther 1 200 · 2026-07-15
- VP-Global Tax and Treasurer · Common Stock, $0.01 par valueOther 221 · 2026-07-15
- VP and CFO · Common Stock, $0.01 par valueOther 1 470 · 2026-07-15
- VP, General Counsel and CCO · Common Stock, $0.01 par valueOther 1 344 · 2026-07-15
- VP, General Counsel and CCO · Common Stock, $0.01 par valueOther 850 · 2026-07-15
- VP Corp. Benefits/Risk Mgmt. · Common Stock, $0.01 par valueOther 1 200 · 2026-07-15
- Director, Chairman and CEO · Common Stock, $0.01 par valueOther 7 160 · 2026-07-15
- President & COO · Common Stock, $0.01 par valueOther 1 470 · 2026-07-15
- President & COO · Common Stock, $0.01 par valueOther 1 717 · 2026-07-15
- VP Corp. Benefits/Risk Mgmt. · Common Stock, $0.01 par valueOther 1 107 · 2026-07-15
- VP and CFO · Common Stock, $0.01 par valueOther 959 · 2026-07-15
- VP and CFO · Common Stock, $0.01 par valueOther 925 @ $105,97$98K · 2026-05-31
- Director, Chairman and CEO · Common Stock, $0.01 par valueOther 496 @ $105,97$53K · 2026-05-31
- VP-Global Tax and Treasurer · Common Stock, $0.01 par valueOther 224 @ $105,97$24K · 2026-05-31
- VP Corp. Benefits/Risk Mgmt. · Common Stock, $0.01 par valueOther 748 @ $105,97$79K · 2026-05-31
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Interest expense (annual): USD 111.54MUnknown
- Operating cash flow (annual): USD 898.71MUnknown
- Net income (annual): USD 661.39MUnknown
- Revenue (annual): USD 7.86BUnknown
- EPS (basic) (annual): USD-PER-SHARES 5Unknown
- Gross profit (annual): USD 3.26BUnknown
- Cost of revenue (annual): USD 4.61BUnknown
- R&D expense (annual): USD 97.9MUnknown
- EPS (diluted) (annual): USD-PER-SHARES 5Unknown
- Pre-tax income (annual): USD 870.34MUnknown
- Cash & equivalents (YoY) (2025-11-30 vs 2024-11-30): 17.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-11-30 vs 2024-11-30): 15.2%Derived (calculated)
- Total assets (YoY) (2025-11-30 vs 2024-11-30): 17.8%Derived (calculated)
- Current ratio (FY 2025-11-30): 2.22xDerived (calculated)
- Total assets (annual): USD 7.87BSEC XBRL filing
- Cash & equivalents (annual): USD 316.59MSEC XBRL filing
- Current assets (annual): USD 3.12BSEC XBRL filing
- Current liabilities (annual): USD 1.41BSEC XBRL filing
- Shareholders' equity (annual): USD 3.13BSEC XBRL filing
- Shares outstanding (annual): 128.08MSEC XBRL filing
- Gross profit (YoY) (2025-05-31 vs 2024-05-31): 1.2%Derived (calculated)
- EPS (diluted) (YoY) (2025-05-31 vs 2024-05-31): 17.3%Derived (calculated)
- Cost of revenue (YoY) (2025-05-31 vs 2024-05-31): 0.0%Derived (calculated)
- Net margin (FY 2025-05-31): 9.3%Derived (calculated)